{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T09:12:03Z","timestamp":1778749923733,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013066","name":"Key Scientific Research Project of Colleges and Universities in Henan Province","doi-asserted-by":"publisher","award":["24A310024"],"award-info":[{"award-number":["24A310024"]}],"id":[{"id":"10.13039\/501100013066","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.prp.2025.156042","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T19:34:32Z","timestamp":1748374472000},"page":"156042","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Targeting CDH11 with celecoxib and derivatives to suppress esophageal squamous cell carcinoma proliferation and invasion"],"prefix":"10.1016","volume":"272","author":[{"given":"Lin","family":"Xiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingbing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yijuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiarui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanjing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minjing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengmeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueyan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3204-1379","authenticated-orcid":false,"given":"Fang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.prp.2025.156042_bib1","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.gie.2018.04.2352","article-title":"Screening for esophageal squamous cell carcinoma: recent advances","volume":"88","author":"Codipilly","year":"2018","journal-title":"Gastrointest. Endosc."},{"issue":"1","key":"10.1016\/j.prp.2025.156042_bib2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1158\/1055-9965.EPI-15-0578","article-title":"Global cancer incidence and mortality rates and trends\u2014an update","volume":"25","author":"Torre","year":"2016","journal-title":"Cancer Epidemiol., Biomark. Prev."},{"issue":"11","key":"10.1016\/j.prp.2025.156042_bib3","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1016\/j.apsb.2021.03.008","article-title":"Advances and challenges in the treatment of esophageal cancer","volume":"11","author":"He","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"3","key":"10.1016\/j.prp.2025.156042_bib4","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1053\/j.gastro.2022.05.054","article-title":"The global landscape of esophageal squamous cell carcinoma and esophageal adenocarcinoma incidence and mortality in 2020 and projections to 2040: new estimates from globocan 2020","volume":"163","author":"Morgan","year":"2022","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.prp.2025.156042_bib5","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.3390\/cancers14061522","article-title":"Toward targeted therapies in oesophageal cancers: an overview","volume":"14","author":"Bregni","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.prp.2025.156042_bib6","doi-asserted-by":"crossref","first-page":"33","DOI":"10.20892\/j.issn.2095-3941.2016.0093","article-title":"Epidemiology, etiology, and prevention of esophageal squamous cell carcinoma in China","volume":"14","author":"He","year":"2017","journal-title":"Cancer Biol. Med."},{"issue":"3","key":"10.1016\/j.prp.2025.156042_bib7","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3390\/cancers15030765","article-title":"Current status and future prospects for esophageal cancer","volume":"15","author":"Sheikh","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.prp.2025.156042_bib8","doi-asserted-by":"crossref","unstructured":"Siegel R.L., Miller K.D., Wagle N.S., et al. Cancer statistics, 2023 [J]. CA: A Cancer Journal for Clinicians, 2023, 73(1): 17-48.","DOI":"10.3322\/caac.21763"},{"key":"10.1016\/j.prp.2025.156042_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2024.155744","article-title":"STC1 promotes esophageal squamous cell carcinoma progression and is associated with poor prognosis","volume":"265","author":"Xu","year":"2025","journal-title":"Pathol. Res Pract."},{"issue":"6","key":"10.1016\/j.prp.2025.156042_bib10","doi-asserted-by":"crossref","first-page":"H1614","DOI":"10.1152\/ajpheart.00277.2018","article-title":"Cadherin-11 as a regulator of valve myofibroblast mechanobiology","volume":"315","author":"Bowler","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"6","key":"10.1016\/j.prp.2025.156042_bib11","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.3109\/s10165-012-0806-7","article-title":"Role of cadherin-11 in synovial joint formation and rheumatoid arthritis pathology","volume":"23","author":"Dou","year":"2013","journal-title":"Mod. Rheuma"},{"issue":"4","key":"10.1016\/j.prp.2025.156042_bib12","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.7150\/jca.52720","article-title":"Research progress in the role and mechanism of Cadherin-11 in different diseases","volume":"12","author":"Chen","year":"2021","journal-title":"J. Cancer"},{"issue":"7","key":"10.1016\/j.prp.2025.156042_bib13","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1002\/anie.201910373","article-title":"Chemical antibody mimics inhibit cadherin-mediated cell-cell adhesion: a promising strategy for cancer therapy","volume":"59","author":"Medina Rangel","year":"2020","journal-title":"Angew. Chem. Int Ed. Engl."},{"key":"10.1016\/j.prp.2025.156042_bib14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.phrs.2018.01.026","article-title":"The tip link protein cadherin-23: from hearing loss to cancer","volume":"130","author":"Vanniya","year":"2018","journal-title":"Pharm. Res"},{"key":"10.1016\/j.prp.2025.156042_bib15","article-title":"Expression profile and prognostic values of CDH family members in lung adenocarcinoma","volume":"2022","author":"Li","year":"2022","journal-title":"Dis. Markers"},{"key":"10.1016\/j.prp.2025.156042_bib16","article-title":"Aberrant cadherin11 expression predicts distant metastasis of gastric cancer","volume":"242","author":"Hideaki","year":"2023","journal-title":"Pathol. Res Pract."},{"issue":"11","key":"10.1016\/j.prp.2025.156042_bib17","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1158\/0008-5472.CAN-09-3016","article-title":"Cadherin-11 increases migration and invasion of prostate cancer cells and enhances their interaction with osteoblasts","volume":"70","author":"Huang","year":"2010","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.prp.2025.156042_bib18","first-page":"4011","article-title":"Clinical and prognostic association of oncogene cadherin 11 in gastric cancer","volume":"19","author":"Wang","year":"2020","journal-title":"Oncol. Lett."},{"issue":"4","key":"10.1016\/j.prp.2025.156042_bib19","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1053\/j.gastro.2020.11.044","article-title":"Cadherin 11 promotes immunosuppression and extracellular matrix deposition to support growth of pancreatic tumors and resistance to gemcitabine in mice","volume":"160","author":"Peran","year":"2021","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.prp.2025.156042_bib20","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/path.4011","article-title":"Epigenetic disruption of cadherin-11 in human cancer metastasis","volume":"228","author":"Carmona","year":"2012","journal-title":"J. Pathol."},{"key":"10.1016\/j.prp.2025.156042_bib21","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.2147\/CMAR.S193921","article-title":"Cadherin-11 is inactivated due to promoter methylation and functions in colorectal cancer as a tumour suppressor","volume":"11","author":"Yuan","year":"2019","journal-title":"Cancer Manag Res"},{"issue":"2","key":"10.1016\/j.prp.2025.156042_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8020148","article-title":"Cadherin 11 Inhibition downregulates beta-catenin, deactivates the canonical wnt signalling pathway and suppresses the cancer stem cell-like phenotype of triple negative breast cancer","volume":"8","author":"Satriyo","year":"2019","journal-title":"J. Clin. Med"},{"key":"10.1016\/j.prp.2025.156042_bib23","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.2147\/OTT.S298614","article-title":"CDH11 regulates adhesion and transcellular migration of tongue squamous cell carcinoma","volume":"14","author":"Zheng","year":"2021","journal-title":"Onco Targets Ther."},{"issue":"2","key":"10.1016\/j.prp.2025.156042_bib24","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/toxsci\/kfz104","article-title":"Cancer chemoprevention: preclinical in vivo alternate dosing strategies to reduce drug toxicities","volume":"170","author":"Mohammed","year":"2019","journal-title":"Toxicol. Sci."},{"issue":"4","key":"10.1016\/j.prp.2025.156042_bib25","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbaa357","article-title":"Topological network measures for drug repositioning","volume":"22","author":"Badkas","year":"2021","journal-title":"Brief. Bioinform"},{"issue":"12","key":"10.1016\/j.prp.2025.156042_bib26","article-title":"Recent advances in the development of celecoxib analogs as anticancer agents: a review","volume":"355","author":"Abdelhaleem","year":"2022","journal-title":"Arch. Pharm. (Weinh. )"},{"issue":"23","key":"10.1016\/j.prp.2025.156042_bib27","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1093\/jnci\/94.23.1745","article-title":"Using cyclooxygenase-2 inhibitors as molecular platforms to develop a new class of apoptosis-inducing agents","volume":"94","author":"Zhu","year":"2002","journal-title":"J. Natl. Cancer Inst."},{"issue":"5","key":"10.1016\/j.prp.2025.156042_bib28","doi-asserted-by":"crossref","first-page":"571","DOI":"10.4161\/cbt.4.5.1699","article-title":"Dimethyl-celecoxib (DMC), a derivative of celecoxib that lacks cyclooxygenase-2-inhibitory function, potently mimics the anti-tumor effects of celecoxib on Burkitt's lymphoma in vitro and in vivo","volume":"4","author":"Kardosh","year":"2005","journal-title":"Cancer Biol. Ther."},{"issue":"5","key":"10.1016\/j.prp.2025.156042_bib29","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s11373-007-9173-3","article-title":"Reduced survivin expression and tumor cell survival during chronic hypoxia and further cytotoxic enhancement by the cyclooxygenase-2 inhibitor celecoxib","volume":"14","author":"Kardosh","year":"2007","journal-title":"J. Biomed. Sci."},{"issue":"7","key":"10.1016\/j.prp.2025.156042_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/biom11071049","article-title":"Celecoxib analogues for cancer treatment: an update on osu-03012 and 2,5-dimethyl-celecoxib","volume":"11","author":"Sobolewski","year":"2021","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/j.prp.2025.156042_bib31","doi-asserted-by":"crossref","DOI":"10.3171\/foc.2006.20.4.14","article-title":"Antitumor properties of dimethyl-celecoxib, a derivative of celecoxib that does not inhibit cyclooxygenase-2: implications for glioma therapy","volume":"20","author":"Schonthal","year":"2006","journal-title":"Neurosurg. Focus"},{"key":"10.1016\/j.prp.2025.156042_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154025","article-title":"Preliminary study on the role and mechanism of KIRREL3 in the development of esophageal squamous cell carcinoma","volume":"237","author":"Yang","year":"2022","journal-title":"Pathol. Res Pract."},{"issue":"3","key":"10.1016\/j.prp.2025.156042_bib33","first-page":"209","article-title":"Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.prp.2025.156042_bib34","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1053\/j.gastro.2017.08.023","article-title":"Epidemiology of esophageal squamous cell carcinoma","volume":"154","author":"Abnet","year":"2018","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.prp.2025.156042_bib35","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/bjs.11118","article-title":"Changes in gut hormones, glycaemic response and symptoms after oesophagectomy","volume":"106","author":"Elliott","year":"2019","journal-title":"Br. J. Surg."},{"issue":"6","key":"10.1016\/j.prp.2025.156042_bib36","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1053\/j.gastro.2021.08.007","article-title":"Parallel-Group Controlled Trial of Surgery Versus Chemoradiotherapy in Patients With Stage I Esophageal Squamous Cell Carcinoma","volume":"161","author":"Kato","year":"2021","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.prp.2025.156042_bib37","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/SLA.0000000000002118","article-title":"Clinical and prognostic features of patients with esophageal cancer and multiple primary cancers: a retrospective single-institution study","volume":"267","author":"Baba","year":"2018","journal-title":"Ann. Surg."},{"issue":"5","key":"10.1016\/j.prp.2025.156042_bib38","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/jjco\/hyz034","article-title":"Systemic treatment of advanced esophageal squamous cell carcinoma: chemotherapy, molecular-targeting therapy and immunotherapy","volume":"49","author":"Hirano","year":"2019","journal-title":"Jpn J. Clin. Oncol."},{"key":"10.1016\/j.prp.2025.156042_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.612451","article-title":"Mechanisms of pharmaceutical therapy and drug resistance in esophageal cancer","volume":"9","author":"Mao","year":"2021","journal-title":"Front Cell Dev. Biol."},{"issue":"15","key":"10.1016\/j.prp.2025.156042_bib40","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1242\/jcs.183772","article-title":"Cadherin-11 is a novel regulator of extracellular matrix synthesis and tissue mechanics","volume":"129","author":"Row","year":"2016","journal-title":"J. Cell Sci."},{"issue":"1","key":"10.1016\/j.prp.2025.156042_bib41","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ajpath.2016.09.012","article-title":"Cadherin-11 Is a cell surface marker up-regulated in activated pancreatic stellate cells and is involved in pancreatic cancer cell migration","volume":"187","author":"Birtolo","year":"2017","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.prp.2025.156042_bib42","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1096\/fj.201902613R","article-title":"Cadherin-11 binds to PDGFRbeta and enhances cell proliferation and tissue regeneration via the PDGFR-AKT signaling axis","volume":"34","author":"Liu","year":"2020","journal-title":"FASEB J."},{"issue":"64","key":"10.1016\/j.prp.2025.156042_bib43","doi-asserted-by":"crossref","first-page":"107477","DOI":"10.18632\/oncotarget.22491","article-title":"Interleukin enhancer-binding factor 3 and HOXC8 co-activate cadherin 11 transcription to promote breast cancer cells proliferation and migration","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.prp.2025.156042_bib44","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.scib.2022.02.005","article-title":"Cadherin 11-mediated juxtacrine interaction of gastric cancer cells and fibroblasts promotes metastasis via YAP\/tenascin-C signaling","volume":"67","author":"Ni","year":"2022","journal-title":"Sci. Bull. (Beijing)"},{"key":"10.1016\/j.prp.2025.156042_bib45","article-title":"Cdh11: Roles in different diseases and potential value in disease diagnosis and treatment","volume":"36","author":"Zhang","year":"2023","journal-title":"Biochem Biophys. Rep."},{"key":"10.1016\/j.prp.2025.156042_bib46","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.semcancer.2019.09.020","article-title":"Systems biology based drug repositioning for development of cancer therapy","volume":"68","author":"Turanli","year":"2021","journal-title":"Semin Cancer Biol."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825002353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825002353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:29:38Z","timestamp":1778747378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033825002353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":46,"alternative-id":["S0344033825002353"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2025.156042","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting CDH11 with celecoxib and derivatives to suppress esophageal squamous cell carcinoma proliferation and invasion","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2025.156042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156042"}}